These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 14640547)

  • 1. An alpha helix conformationally restricted peptide is recognized by cervical carcinoma patients' sera.
    Calvo JC; Choconta KC; Diaz D; Orozco O; Bravo MM; Espejo F; Salazar LM; Guzman F; Patarroyo ME
    J Med Chem; 2003 Dec; 46(25):5389-94. PubMed ID: 14640547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two L1-peptides are excellent tools for serological detection of HPV-associated cervical carcinoma lesions.
    Urquiza M; Guevara T; Espejo F; Bravo MM; Rivera Z; Patarroyo ME
    Biochem Biophys Res Commun; 2005 Jun; 332(1):224-32. PubMed ID: 15896321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between serological immune response analyzed by a new ELISA for HPV-16/18 E7 oncoprotein and clinical characteristics of cervical cancer patients.
    Ravaggi A; Romani C; Pasinetti B; Tassi RA; Bignotti E; Bandiera E; Odicino FE; Ragnoli M; Donzelli C; Falchetti M; Calza S; Santin AD; Pecorelli S
    Arch Virol; 2006 Oct; 151(10):1899-916. PubMed ID: 16732494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disease-stage variance in functional CD4(+) T-cell responses against novel pan-human leukocyte antigen-D region presented human papillomavirus-16 E7 epitopes.
    Warrino DE; Olson WC; Knapp WT; Scarrow MI; D'Ambrosio-Brennan LJ; Guido RS; Edwards RP; Kast WM; Storkus WJ
    Clin Cancer Res; 2004 May; 10(10):3301-8. PubMed ID: 15161683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A non-variable L1-peptide displays high sensitivity and specificity for detecting women having human papillomavirus-associated cervical lesions.
    Urquiza M; Guevara T; Sanchez R; Vanegas M; Patarroyo ME
    Peptides; 2008 Jun; 29(6):957-62. PubMed ID: 18294733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serological study in Tunisian cervical cancer patients.
    Achour M; Kochbati L; Zeghal D; Kahla S; Maalej M; Zouari F; Oueslati R
    Pathol Biol (Paris); 2009 Jul; 57(5):415-9. PubMed ID: 18586408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase I immunotherapeutic trial with long peptides spanning the E6 and E7 sequences of high-risk human papillomavirus 16 in end-stage cervical cancer patients shows low toxicity and robust immunogenicity.
    Kenter GG; Welters MJ; Valentijn AR; Lowik MJ; Berends-van der Meer DM; Vloon AP; Drijfhout JW; Wafelman AR; Oostendorp J; Fleuren GJ; Offringa R; van der Burg SH; Melief CJ
    Clin Cancer Res; 2008 Jan; 14(1):169-77. PubMed ID: 18172268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Expression purification and clinical application of high-risk HPV16 E4 gene].
    Gao YE; Hui H; Zhang J; Fan JB; Yan XJ
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Aug; 33(8):676-81. PubMed ID: 18772505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of tumor-specific CD4+ and CD8+ T-cell immunity in cervical cancer patients by a human papillomavirus type 16 E6 and E7 long peptides vaccine.
    Welters MJ; Kenter GG; Piersma SJ; Vloon AP; Löwik MJ; Berends-van der Meer DM; Drijfhout JW; Valentijn AR; Wafelman AR; Oostendorp J; Fleuren GJ; Offringa R; Melief CJ; van der Burg SH
    Clin Cancer Res; 2008 Jan; 14(1):178-87. PubMed ID: 18172269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccination of healthy volunteers with human papillomavirus type 16 L2E7E6 fusion protein induces serum antibody that neutralizes across papillomavirus species.
    Gambhira R; Gravitt PE; Bossis I; Stern PL; Viscidi RP; Roden RB
    Cancer Res; 2006 Dec; 66(23):11120-4. PubMed ID: 17145854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expression, purification, and serum antibody detection of HPV16 E6 in cervical cancer patients].
    Gao YE; Guo JZ; Zhang J; Song TB; Yan XJ
    Ai Zheng; 2006 Nov; 25(11):1374-9. PubMed ID: 17094904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surface simulation synthesis: a new strategy to spy alpha-helix structure.
    Dong XN; Chen Y; Chen YH
    Vaccine; 2007 Sep; 25(36):6569-71. PubMed ID: 17055133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and characterization of helical peptides that inhibit the E6 protein of papillomavirus.
    Liu Y; Liu Z; Androphy E; Chen J; Baleja JD
    Biochemistry; 2004 Jun; 43(23):7421-31. PubMed ID: 15182185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasmid encoding papillomavirus Type 16 (HPV16) DNA constructed with codon optimization improved the immunogenicity against HPV infection.
    Cheung YK; Cheng SC; Sin FW; Xie Y
    Vaccine; 2004 Dec; 23(5):629-38. PubMed ID: 15542183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NMR probing of in silico identification of anti-HPV16 E7 mAb linear peptide epitope.
    Kanduc D; Fanizzi FP; Lucchese G; Stevanovic S; Sinha AA; Mittelman A
    Peptides; 2004 Feb; 25(2):243-50. PubMed ID: 15063005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA vaccines based on chimeric potyvirus-like particles carrying HPV16 E7 peptide (aa 44-60).
    Pokorna D; Cerovska N; Smahel M; Moravec T; Ludvikova V; Mackova J; Synkova H; Duskova M; Hozak P; Veleminsky J
    Oncol Rep; 2005 Oct; 14(4):1045-53. PubMed ID: 16142370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of human papillomavirus 16-E6 protein-derived peptides with the potential to generate cytotoxic T-lymphocytes toward human leukocyte antigen-A24+ cervical cancer.
    Hara M; Matsueda S; Tamura M; Takedatsu H; Tanaka M; Kawano K; Mochizuki K; Kamura T; Itoh K; Harada M
    Int J Oncol; 2005 Nov; 27(5):1371-9. PubMed ID: 16211234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selection of antibody fragments specific for an alpha-helix region of acylphosphatase.
    Degl'Innocenti D; Taddei N; Ramazzotti M; Stefani M; Chiti F; Ramponi G
    J Mol Recognit; 2004; 17(1):62-6. PubMed ID: 14872538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Shortening and modifying the 1513 MSP-1 peptide's alpha-helical region induces protection against malaria.
    Espejo F; Bermúdez A; Torres E; Urquiza M; Rodríguez R; López Y; Patarroyo ME
    Biochem Biophys Res Commun; 2004 Mar; 315(2):418-27. PubMed ID: 14766224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antisense targeting human papillomavirus type 16 E6 and E7 genes contributes to apoptosis and senescence in SiHa cervical carcinoma cells.
    Sima N; Wang S; Wang W; Kong D; Xu Q; Tian X; Luo A; Zhou J; Xu G; Meng L; Lu Y; Ma D
    Gynecol Oncol; 2007 Aug; 106(2):299-304. PubMed ID: 17586029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.